Circulation, Vol 57, 751-755, Copyright © 1978 by American Heart Association
F Hagemeijer
In 16 patients, a sustained supraventricular tachyarrhythmia occurring less
than 72 hours after the first symptom of an acute myocardial infarction was
treated with titrated doses of verapamil. The drug was given intravenously
in 1 mg increments every minute under continuous monitoring of
electrocardiogram and blood pressure. Endpoints for the administration of
verapamil were the following: reversion to sinus rhythm; a ventricular rate
slower than 100/min; hypotension; a pulmonary capillary wedge pressure
rising above 15 mm Hg; signs of intolerance; a maximum dose of 20 mg.
Reversion to sinus rhythm was observed in 7/8 patients in atrial flutter
and in 1/8 patients in atrial fibrillation; in all the ventricular rate
could be slowed below 100/min without untoward effects.
ARTICLES
Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction
This article has been cited by other articles:
![]() |
B. N. Singh Pharmacological Basis for the Therapeutic Applications of Slow-Channel Blocking Drugs Angiology, August 1, 1982; 33(8): 492 - 515. [PDF] |
||||
![]() |
J. A. Abbott Intravenous Antiarrhythmic Drugs: Newer Aspects of Therapy Angiology, April 1, 1982; 33(4): 251 - 258. [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1978 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |